Non-invasive eye scans allow doctors a zoomed-in, three-dimensional look beneath the eye's surface without causing discomfort ...

Shares of Alvotech ALVO, a biotechnology company specializing in the development and manufacturing of biosimilar medicines, ...

Ocugen OCGN is advancing a retinal pipeline built around durability and breadth. Its focus is a modifier gene therapy ...

“We can probably edit almost any gene, but that doesn’t mean we should,” Dan Rosan, chief financial and business officer of Ascidian Therapeutics, told Fierce Biotech. That thinking has shaped how the ...

Dysfunction of the ocular glymphatic system may lead to the accumulation of neurotoxic proteins, providing a mechanistic link between ophthalmic conditions and neurodegenerative diseases. Glymphatic ...

Ocugen frames 2026 as pivotal because it expects meaningful milestones across all three core ocular programs in the same year ...

Consultant ophthalmologist post for South Tipperary became vacant in autumn 2024, but HSE recruitment campaign has failed to attract suitable candidate ...

The Kingdom of Saudi Arabia is advancing a modern health model centred on innovative technologies, particularly artificial ...

Detailed price information for Opus Genetics Inc (IRD-Q) from The Globe and Mail including charting and trades.

The Driver and Vehicle Licensing Agency requires drivers to report certain notifiable medical conditions that could affect their ability to drive safely ...

Notifiable conditions are medical issues that could affect your ability to drive safely. These can include sleep apnoea, ...